GGrantIndex
Sort

16,300 grants matching fatty liver disease

Molecular Prognostic Indicators in Liver Cirrhosis and Cancer

$683,136
Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DK

Molecular Prognostic Indicators in Liver Cirrhosis and Cancer

$683,136
Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DK

HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression

$682,950
Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2020 · DK

In vivo HTS assay for novel modulators of Apolipoprotein B

$682,895
Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2018 · DK

Thyroid Hormone Signaling in Human Hepatocytes

$682,749
Anthony N Hollenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK

Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance

$682,727
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2023 · HL

Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseases

$682,718
Joel David Schilling · Washington University · R01 · FY2022 · DK

Novel Isoform-specific Targeting of PKA

$682,704
Susan S Taylor · University Of California, San Diego · P01 · FY2014 · DK

Rabbit model for cystic fibrosis

$682,527
Fei Sun · Wayne State University · R01 · FY2016 · HL

Development of Oral Small Molecule PCSK9 Antagonist

$682,343
Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2017 · HL

Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers

$682,158
Luke Norton · University Of Texas Hlth Science Center · R01 · FY2023 · DK

Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers

$682,154
Luke Norton · University Of Texas Hlth Science Center · R01 · FY2025 · DK

Biobehavioral Studies of Obesity, Weight loss and Recidivism

$682,029
Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Dietary Regulation of Intestinal Inflammation and Repair

$681,939
David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK

Dietary Regulation of Intestinal Inflammation and Repair

$681,939
David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK

Dietary Regulation of Intestinal Inflammation and Repair

$681,939
David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK

Project 2: The UPR transducer ATF6 drives HCC in response to metabolic stress

$681,823
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · CA

The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes

$681,677
Sheela Natesh Magge · Johns Hopkins University · U01 · FY2025 · DK

Development of a Urine Test for the Early Detection of Liver Cancer

$681,583
Surbhi Jain · Jbs Science, Inc. · R44 · FY2013 · CA

LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS

$681,226
Arun J Sanyal · Virginia Commonwealth University · R01 · FY2018 · DK

Multimodal omics approach to identify health to cardiometabolic disease transitions

$681,062
Paivi Pajukanta · University Of California Los Angeles · R01 · FY2024 · HL

Guided imagery lifestyle intervention to prevent & treat obesity in Latino youth

$680,630
Marc J Weigensberg · University Of Southern California · R01 · FY2013 · AT

Understanding the Multilevel Drivers of Liver Cancer Disparities

$680,549
Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2019 · CA

Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD

$680,547
David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK

The Molecular Profile of Prostate Tumors in African-American Men

$680,523
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA